Sage Journals: Discover world-class research

Open access

Review article

First published 2011

Current and Emerging Therapies in Peripheral T-cell Lymphoma: Focus on Pralatrexate

Thanyanan Reungwetwattana, Sylvia Jaramillo, Julian R. Molina

Clinical Medicine Insights: Therapeutics

Free access

Research article

First published 2012-8

Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma

Enrica Marchi, Owen A. O’Connor

Therapeutic Advances in Hematology

Open access

Review article

First published 2012

Safety and Efficacy of Pralatrexate in the Management of Relapsed or Refractory Peripheral T-cell Lymphoma

Annabelle L. Rodd, Katherine Ververis, Tom C. Karagiannis

Clinical Medicine Insights: Oncology

Retricted access

Review article

First published 2012-6

Pralatrexate: A novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses

John Hui, Eugene Przespo, Anjana Elefante

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2010-2

Pazopanib;Pralatrexate

Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Free access

Review article

First published 2013-6

Novel therapies for peripheral T-cell lymphomas

Andrei Shustov

Therapeutic Advances in Hematology

Open access

Abstract

First published 2022-10

Bilateral Hindfoot Osteonecrosis Associated with Treatment for Cutaneous T-Cell Lymphoma

Gianni Ricci, Eric H. Gruenberger, Matthew G. Stewart

Foot & Ankle Orthopaedics

Retricted access

Research article

First published 2009-12

Dronedarone

Dennis J. Cada, Terri L. Levien, Danial E. Baker

Hospital Pharmacy

Search results